Hall H - Search Results

1

Pharmacodynamic markers of perifosine efficacy.

Hennessy BT, Lu Y, Poradosu E, Yu Q, Yu S, Hall H, Carey MS, Ravoori M, Gonzalez-Angulo AM, Birch R, Henderson IC, Kundra V, Mills GB. Hennessy BT, et al. Among authors: hall h. Clin Cancer Res. 2007 Dec 15;13(24):7421-31. doi: 10.1158/1078-0432.CCR-07-0760. Clin Cancer Res. 2007. PMID: 18094426

2

Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages.

Visentin B, Vekich JA, Sibbald BJ, Cavalli AL, Moreno KM, Matteo RG, Garland WA, Lu Y, Yu S, Hall HS, Kundra V, Mills GB, Sabbadini RA. Visentin B, et al. Cancer Cell. 2006 Mar;9(3):225-38. doi: 10.1016/j.ccr.2006.02.023. Cancer Cell. 2006. PMID: 16530706 Free article.

3

Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells.

Yu S, Murph MM, Lu Y, Liu S, Hall HS, Liu J, Stephens C, Fang X, Mills GB. Yu S, et al. J Natl Cancer Inst. 2008 Nov 19;100(22):1630-42. doi: 10.1093/jnci/djn378. Epub 2008 Nov 11. J Natl Cancer Inst. 2008. PMID: 19001604 Free PMC article.

4

Dual inhibition of tumor energy pathway by 2-deoxyglucose and metformin is effective against a broad spectrum of preclinical cancer models.

Cheong JH, Park ES, Liang J, Dennison JB, Tsavachidou D, Nguyen-Charles C, Wa Cheng K, Hall H, Zhang D, Lu Y, Ravoori M, Kundra V, Ajani J, Lee JS, Ki Hong W, Mills GB. Cheong JH, et al. Among authors: hall h. Mol Cancer Ther. 2011 Dec;10(12):2350-62. doi: 10.1158/1535-7163.MCT-11-0497. Epub 2011 Oct 12. Mol Cancer Ther. 2011. PMID: 21992792 Free PMC article.

5

Lysophosphatidic acid-induced transcriptional profile represents serous epithelial ovarian carcinoma and worsened prognosis.

Murph MM, Liu W, Yu S, Lu Y, Hall H, Hennessy BT, Lahad J, Schaner M, Helland A, Kristensen G, Børresen-Dale AL, Mills GB. Murph MM, et al. Among authors: hall h. PLoS One. 2009;4(5):e5583. doi: 10.1371/journal.pone.0005583. Epub 2009 May 15. PLoS One. 2009. PMID: 19440550 Free PMC article.

6

Molecular therapeutics: promise and challenges.

Kohn EC, Lu Y, Wang H, Yu Q, Yu S, Hall H, Smith DL, Meric-Bernstam F, Hortobagyi GN, Mills GB. Kohn EC, et al. Among authors: hall h. Semin Oncol. 2004 Feb;31(1 Suppl 3):39-53. doi: 10.1053/j.seminoncol.2004.01.009. Semin Oncol. 2004. PMID: 15052542 Review.

7

Homozygous deletion of glycogen synthase kinase 3beta bypasses senescence allowing Ras transformation of primary murine fibroblasts.

Liu S, Fang X, Hall H, Yu S, Smith D, Lu Z, Fang D, Liu J, Stephens LC, Woodgett JR, Mills GB. Liu S, et al. Among authors: hall h. Proc Natl Acad Sci U S A. 2008 Apr 1;105(13):5248-53. doi: 10.1073/pnas.0704242105. Epub 2008 Mar 26. Proc Natl Acad Sci U S A. 2008. PMID: 18367674 Free PMC article.

8

Targeting melanoma growth and viability reveals dualistic functionality of the phosphonothionate analogue of carba cyclic phosphatidic acid.

Altman MK, Gopal V, Jia W, Yu S, Hall H, Mills GB, McGinnis AC, Bartlett MG, Jiang G, Madan D, Prestwich GD, Xu Y, Davies MA, Murph MM. Altman MK, et al. Among authors: hall h. Mol Cancer. 2010 Jun 9;9:140. doi: 10.1186/1476-4598-9-140. Mol Cancer. 2010. PMID: 20529378 Free PMC article.

9

Pre-operative expectations of patients with degenerative cervical myelopathy: an observational study from the Canadian Spine Outcomes and Research Network.

Althagafi A, Dea N, Evaniew N, Rampersaud RY, Jacobs WB, Paquet J, Wilson JR, Hall H, Bailey CS, Weber MH, Nataraj A, Attabib N, Cadotte DW, Phan P, Christie SD, Fisher CG, Manson N, Thomas K, McIntosh G, Charest-Morin R. Althagafi A, et al. Among authors: hall h. Spine J. 2024 Apr 26:S1529-9430(24)00186-4. doi: 10.1016/j.spinee.2024.04.027. Online ahead of print. Spine J. 2024. PMID: 38679073 Free article.

10

Optically Transparent Lead Halide Perovskite Polycrystalline Ceramics.

Brennan MC, McCleese CL, Loftus LM, Lipp J, Febbraro M, Hall HJ, Turner DB, Carter MJ, Stevenson PR, Grusenmeyer TA. Brennan MC, et al. Among authors: hall hj. ACS Appl Mater Interfaces. 2024 Mar 27;16(12):15084-15095. doi: 10.1021/acsami.4c01517. Epub 2024 Mar 18. ACS Appl Mater Interfaces. 2024. PMID: 38498384

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,377 results

Search Page